...Mkt (generic) TFF Pharmaceuticals Inc. 8/20/19 $22.0 Preclin Monopar Therapeutics Inc. 8/15/19 $40 Ph II Frontier Biotechnologies Co. Ltd....

...lost 2.8%. Frontier to list in Shanghai The Shanghai Stock Exchange accepted an application from Frontier Biotechnologies Co. Ltd....
...company's directional Genomic Hybridization platform assesses cell samples to detect DNA sequences, location and orientation. BioCentury Staff Albuvirtide Frontier Biotechnologies Co. Ltd. KromaTiD...

...Inc., Suzhou Zelgen Biopharmaceuticals Co. Ltd., BrightGene Bio-medical Technology Co. Ltd., Bio-Thera Solutions Ltd. and Frontier Biotechnologies Co. Ltd....

...is a long-acting viral entry inhibitor targeting HIV gp41. Frontier Biotechnologies Co. Ltd., Nanjing, China Business: Infectious Jaime De Leon Albuvirtide Frontier Biotechnologies Co. Ltd. HIV...

...to originate in China. Albuvirtide is a long-acting viral entry inhibitor targeting HIV gp41. Jaime De Leon Albuvirtide Frontier Biotechnologies Co. Ltd. HIV...

...and Roche market Fuzeon enfuvirtide, a HIV gp41 viral fusion inhibitor peptide analog, for HIV/AIDS. Frontier Biotechnologies Co. Ltd....

...lamivudine and ritonavir-boosted lopinavir. Albuvirtide is a long-acting viral entry inhibitor targeting HIV gp41 . Becky Simon Albuvirtide Frontier Biotechnologies...

...Group. Shenzhen Capital Group, EFung Capital and undisclosed investors also participated. Frontier Biotechnologies Co. Ltd. , Nanjing, China Alex Himes Frontier Biotechnologies Co. Ltd....

...daily in the morning for 14 days. Patches were to be removed after 12 hours. Frontier Biotechnologies Co. Ltd....